Beam Therapeutics Inc. News, Beam Therapeutics Inc. Quote, BEAM Quote

Beam Therapeutics Inc. (NQ:BEAM) Delayed: 27.48 +0.23 (0.84%)

Prev. Close

$27.25

Today 6M 1Y 5Y

Open

$27.71

52 Wk High

$83.60

52 Wk Low

$82.96

Day High

$28.35

Day Low

$27.13

P/E

12.27

EPS

$2.24

Volume

1,324,259

Friends, Peers and Foes (?): CRSP, NTLA, EDIT, DTIL, MGX (more...)

ALERTS | RSS

Aug 5, 2026 08:11 AM Beam Therapeutics Inc (BEAM) PT Raised to $240 at JPMorgan
Aug 4, 2026 07:14 AM Form 10-Q Beam Therapeutics Inc. For: Jun 30
Aug 4, 2026 07:14 AM Beam, Inc. (BEAM) Misses Q2 EPS by 8c
Aug 4, 2026 07:09 AM Form 8-K Beam Therapeutics Inc. For: Aug 04
Aug 4, 2026 07:00 AM Beam Therapeutics posts Q2 loss, doses first patient in BEAM-302 trial
Aug 4, 2026 07:00 AM Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)
Jul 29, 2026 04:05 PM Form 4 Beam Therapeutics Inc. For: Jul 27 Filed by: Simon Amy
Jul 27, 2026 04:05 PM Form 144 Beam Therapeutics Inc. Filed by: Simon Amy
Jul 23, 2026 07:00 AM Beam Therapeutics to present BEAM-302 trial data at ERS 2026
Jul 23, 2026 07:00 AM Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congres

Entities mentioned with BEAM

View All Entities